Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q4 Adjusted EBITDA Rises To SEK 19.8 Mln

Jan 26 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * REPORT ON OPERATIONS 2022
    * Q4 NET SALES SEK 131.5 MILLION VERSUS SEK 85.9 MILLION
YEAR AGO
    * Q4 ADJUSTED EBITDA SEK 19.8 MILLION VERSUS SEK 9.6 MILLION
YEAR
AGO
    * Q4 NET PROFIT SEK 0.7 MILLION VERSUS NET SEK 12.2 MILLION
YEAR
AGO
    * BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND BE PAID FOR
2022
FINANCIAL YEAR AND THAT RETAINED EARNINGS BE CARRIED FORWARD

Source text for Eikon:  ID:nMFNGf7H0 
Further company coverage:  XVIVO.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xvivo Perfusion AB

See all news